GHRH analogue and visceral adipose tissue
New England Journal of Medicine · 2007
A randomised trial reported significant reductions in visceral adipose tissue with a stabilised GHRH analogue, without meaningful change in subcutaneous fat.
peptides
Tesamorelin10mg
$79.99
A growth hormone releasing hormone analogue studied for its effects on body composition research endpoints.
- Purity
- ≥99% (HPLC)
- Form
- Lyophilized powder
- Vial
- 10mg
- Testing
- Third-party assayed
1
- Free shipping on orders $199+
- Unbranded, discreet packaging
From the literature
Tesamorelin research
Research articles about Tesamorelin
Effects on hepatic fat in metabolic research
The Lancet HIV · 2019
Follow-up work found reductions in liver fat fraction and progression of fibrosis markers, expanding interest in GHRH analogues beyond body-composition endpoints.
Summaries of published literature, provided for context only. Nothing here is medical advice, and this product is sold for laboratory research use only.
Pairs well with
Related research
Related products
Retatrutide 10mg
$89.99Triple-agonist research compound.
Tirzepatide 10mg
$59.99Dual-agonist metabolic research.
Cagrilintide 5mg
$74.99Long-acting amylin analogue.
BPC-157 5mg
$49.99Body protection compound.
Tesamorelin
$79.99